These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30762807)

  • 1. Surveillance of non-muscle invasive bladder cancer using fluorescence in situ hybridization: Protocol for a systematic review and meta-analysis.
    Lin T; Jin H; Gong L; Yu R; Sun S; Yang L; Zhang P; Han P; Cheng J; Liu L; Wei Q
    Medicine (Baltimore); 2019 Feb; 98(7):e14573. PubMed ID: 30762807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy.
    Kim PH; Sukhu R; Cordon BH; Sfakianos JP; Sjoberg DD; Hakimi AA; Dalbagni G; Lin O; Herr HW
    BJU Int; 2014 Sep; 114(3):354-9. PubMed ID: 24128299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Fluorescence In Situ Hybridization in the Surveillance of Non-Muscle Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis.
    Zheng W; Lin T; Chen Z; Cao D; Bao Y; Zhang P; Yang L; Wei Q
    Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature.
    Rink M; Babjuk M; Catto JW; Jichlinski P; Shariat SF; Stenzl A; Stepp H; Zaak D; Witjes JA
    Eur Urol; 2013 Oct; 64(4):624-38. PubMed ID: 23906669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis.
    Laukhtina E; Shim SR; Mori K; D'Andrea D; Soria F; Rajwa P; Mostafaei H; Compérat E; Cimadamore A; Moschini M; Teoh JY; Enikeev D; Xylinas E; Lotan Y; Palou J; Gontero P; Babjuk M; Witjes JA; Kamat AM; Roupret M; Shariat SF; Pradere B;
    Eur Urol Oncol; 2021 Dec; 4(6):927-942. PubMed ID: 34753702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive comparison of fluorescence in situ hybridization and cytology for the detection of upper urinary tract urothelial carcinoma: A systematic review and meta-analysis.
    Jin H; Lin T; Hao J; Qiu S; Xu H; Yu R; Sun S; Zhang P; Liu Z; Yang L; Liu L; Han P; Wei Q
    Medicine (Baltimore); 2018 Dec; 97(52):e13859. PubMed ID: 30593189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review.
    Soukup V; Čapoun O; Cohen D; Hernández V; Babjuk M; Burger M; Compérat E; Gontero P; Lam T; MacLennan S; Mostafid AH; Palou J; van Rhijn BWG; Rouprêt M; Shariat SF; Sylvester R; Yuan Y; Zigeuner R
    Eur Urol; 2017 Nov; 72(5):801-813. PubMed ID: 28457661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence in situ hybridization as prognostic predictor of tumor recurrence during treatment with Bacillus Calmette-Guérin therapy for intermediate- and high-risk non-muscle-invasive bladder cancer.
    Liem EIML; Baard J; Cauberg ECC; Bus MTJ; de Bruin DM; Laguna Pes MP; de la Rosette JJMCH; de Reijke TM
    Med Oncol; 2017 Sep; 34(10):172. PubMed ID: 28866819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading.
    Lodde M; Mian C; Mayr R; Comploj E; Trenti E; Melotti R; Campodonico F; Maffezzini M; Fritsche HM; Pycha A
    Int J Urol; 2014 Oct; 21(10):968-72. PubMed ID: 24947145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Fluorescence In Situ Hybridization for Predicting Recurrence after Adjuvant bacillus Calmette-Guérin in Patients with Intermediate and High Risk Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data.
    Liem EIML; Oddens JR; Vernooij RWM; Li R; Kamat A; Dinney CP; Mengual L; Alcaraz A; Izquierdo L; Savic S; Thalmann GN; Bubendorf L; Sylvester RJ; de Reijke TM
    J Urol; 2020 Feb; 203(2):283-291. PubMed ID: 31549936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer.
    Shepherd AR; Shepherd E; Brook NR
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012112. PubMed ID: 28268259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical Therapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease Recurrence.
    Laukhtina E; Abufaraj M; Al-Ani A; Ali MR; Mori K; Moschini M; Quhal F; Sari Motlagh R; Pradere B; Schuettfort VM; Mostafaei H; Katayama S; Grossmann NC; Fajkovic H; Soria F; Enikeev D; Shariat SF;
    Eur Urol Focus; 2022 Mar; 8(2):447-456. PubMed ID: 33762203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis.
    Kardoust Parizi M; Enikeev D; Glybochko PV; Seebacher V; Janisch F; Fajkovic H; Chłosta PL; Shariat SF
    World J Urol; 2020 Jun; 38(6):1437-1449. PubMed ID: 31493109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of fluorescence in situ hybridization for diagnosis and surveillance of bladder urothelial carcinoma.
    Huang JW; Mu JG; Li YW; Gan XG; Song LJ; Gu BJ; Fu Q; Xu YM; An RH
    Urol J; 2014 Nov; 11(6):1974-9. PubMed ID: 25433477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender-specific Differences in Recurrence of Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Uhlig A; Strauss A; Seif Amir Hosseini A; Lotz J; Trojan L; Schmid M; Uhlig J
    Eur Urol Focus; 2018 Dec; 4(6):924-936. PubMed ID: 28888813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active surveillance for non-muscle invasive bladder cancer: A systematic review and pooled-analysis.
    Petrelli F; Giannatempo P; Maccagnano C; Contieri R; Hurle R
    Cancer Treat Res Commun; 2021; 27():100369. PubMed ID: 33838570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xpert bladder cancer monitor in surveillance of bladder cancer: Systematic review and meta-analysis.
    Sharma G; Sharma A; Krishna M; Devana SK; Singh SK
    Urol Oncol; 2022 Apr; 40(4):163.e1-163.e9. PubMed ID: 34535354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis.
    Vartolomei MD; Porav-Hodade D; Ferro M; Mathieu R; Abufaraj M; Foerster B; Kimura S; Shariat SF
    Urol Oncol; 2018 Sep; 36(9):389-399. PubMed ID: 29884342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.